A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2001
12/20/2001	US20010053351 Inhibition of GSK-3 beta
12/20/2001	DE10037272A1 Identifying agents for treating cardiovascular disease, comprises determining the ability of potential agents to modify interaction between beta3 endonexin and beta3 integrin
12/20/2001	DE10029015A1 Coagulation Factor Xa inhibitor, useful for treatment, prophylaxis or diagnosis of thromboembolic disease, comprising acylated 3- or 4-amidino-benzylamine derivative
12/20/2001	DE10029014A1 Urokinase inhibitor, useful for treatment, prophylaxis or diagnosis of thromboembolic disease, comprising acylated 3- or 4-amidino-benzylamine derivative
12/20/2001	DE10028901A1 New human gene hEDG-8 encoding G-protein coupled receptor, useful for developing treatments and diagnoses for e.g. multiple sclerosis
12/20/2001	DE10028402A1 New pyridinylamino-alkanoyl-glycyl-beta-alanine derivatives, are integrin inhibitors useful for treating, e.g. thrombosis, cardiac infarction, coronary heart disease, inflammation, tumors, osteoporosis or restenosis
12/20/2001	DE10027383A1 Nukleinsäure-Molekül umfassend eine für ein Chemokin, einen Neuropeptid-Präkursor oder mindestens ein Neuropeptid kodierende Nukleinsäuresequenz Nucleic acid molecule comprising a sequence coding for a chemokine, a neuropeptide precursor or at least one neuropeptide nucleic acid sequence
12/20/2001	DE10026666A1 Verwendung von Hyaluronidase zur Prophylaxe und Behandlung von Herz-Kreislauf-Erkrankungen Use of hyaluronidase for the prophylaxis and treatment of cardiovascular diseases
12/20/2001	DE10024171A1 Neuronale Serin-Threonin-Protein-Kinase Neuronal serine threonine protein kinase
12/20/2001	CA2736957A1 Pleiotrophin growth factor receptor for the treatment of proliferative, vascular and neurological disorders
12/20/2001	CA2441161A1 Method of using lectins for contraception and prophylaxis against diseases transmittable by sexual contact and condom containing lectins
12/20/2001	CA2415369A1 Thromboxane receptor antagonist containing formulations for potentiating organic nitrates having vasodilating activity
12/20/2001	CA2413149A1 Prodrug compounds with isoleucine
12/20/2001	CA2413077A1 Interferon for treatment of multiple sclerosis
12/20/2001	CA2412842A1 Combination product for carrying out a cytotoxic treatment in a mammal
12/20/2001	CA2412665A1 Scramblase 2
12/20/2001	CA2412664A1 Regulatable, catalytically active nucleic acids
12/20/2001	CA2412356A1 Immunosuppressor agent derived from morbillivirus
12/20/2001	CA2412355A1 Method of treating symptoms of hormonal variation, including hot flashes, using tachykinin receptor antagonist
12/20/2001	CA2412257A1 Pro-apoptotic fragments of the dengue virus envelope glycoproteins
12/20/2001	CA2412223A1 Compositions and methods for the therapy and diagnosis of colon cancer
12/20/2001	CA2411967A1 Pegylation of linkers improves antitumor activity and reduces toxicity of immunoconjugates
12/20/2001	CA2411962A1 Methods for regulating a cell-mediated immune response by blockinglymphocytic signals and by blocking lfa-1 mediated adhesion
12/20/2001	CA2411472A1 Cd154 variants
12/20/2001	CA2411346A1 Biosynthetic oncolytic molecules and uses therefor
12/20/2001	CA2411278A1 Compositions and methods for the therapy and diagnosis of colon cancer
12/20/2001	CA2411231A1 Codon optimised recombinant dermaphagoides allergens
12/20/2001	CA2410610A1 Human kinases
12/20/2001	CA2410604A1 Use of coiled-coil structural scaffold to generate structure-specific peptides
12/20/2001	CA2410532A1 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro
12/20/2001	CA2410228A1 A combination product comprising melagatran and a factor viia inhibitor
12/20/2001	CA2410100A1 A combination product comprising melagatran and a factor xa inhibitor
12/20/2001	CA2409315A1 Protein phosphatases
12/20/2001	CA2351275A1 Use of polypeptides or nucleic acids for the diagnosis or treatment of skin disorders and wound healing and for the identification of pharmacologically active substances
12/19/2001	EP1164374A1 Method for identifying apoptosis-modified proteins
12/19/2001	EP1164195A2 Adeno-associated virus with inverted terminal repeat sequences as promoter
12/19/2001	EP1164144A1 Insulin receptor-related receptor binding protein and utilization of the same
12/19/2001	EP1164142A1 Novel proteins and uses thereof
12/19/2001	EP1164141A2 Opioid peptides and their use for treatment of pain
12/19/2001	EP1164135A1 Substituted metal-phthalocyanines, their preparation and the use thereof
12/19/2001	EP1163912A1 Gene therapeutics
12/19/2001	EP1163528A2 Prediction of diabetes impaired wound healing
12/19/2001	EP1163524A2 Methods of screening for colorectal cancer modulators
12/19/2001	EP1163522A1 Method for detecting superantigen activity in a biological sample
12/19/2001	EP1163521A2 Assays, methods and means
12/19/2001	EP1163515A1 Therapeutic and diagnostic tools for impaired glucose tolerance conditions
12/19/2001	EP1163373A1 Antisense modulation of cellular inhibitor of apoptosis-1 expression
12/19/2001	EP1163365A1 Diagnosis and therapy of premature ovarian failure
12/19/2001	EP1163349A2 Medical preparations for the treatment of alpha-galactosidase a deficiency
12/19/2001	EP1163346A1 Hybrid synthetase, hybrid peptide and composition containing same
12/19/2001	EP1163342A1 Chlamydia antigens and corresponding dna fragments and uses thereof
12/19/2001	EP1163336A2 Vertebrate protein slit, dna sequence encoding it and uses thereof
12/19/2001	EP1163335A1 MATERIALS AND METHODS RELATING TO MODULATION OF p66 EXPRESSION
12/19/2001	EP1163334A1 Polynucleotide and deduced amino acid sequences from stromal cells
12/19/2001	EP1163333A2 Inhibitors of endothelin-1 synthesis
12/19/2001	EP1163332A1 48 human secreted proteins
12/19/2001	EP1163331A1 50 human secreted proteins
12/19/2001	EP1163273A1 Method for the reductive animation of polysaccharides
12/19/2001	EP1163272A1 Antibodies specific for cyp1b1
12/19/2001	EP1163270A1 Dihydroouabain-like factor and diagnostic and therapeutic compositions and methods
12/19/2001	EP1163269A1 ISOFORMS OF MOUSE SEROTONIN 5-HT2c RECEPTOR
12/19/2001	EP1163267A1 47 human secreted proteins
12/19/2001	EP1163264A1 Novel lhrh antagonists with improved solubility characteristics
12/19/2001	EP1163263A1 Dalda analogs and their use
12/19/2001	EP1163262A1 Phenylalanine derivatives
12/19/2001	EP1163255A1 50 human secreted proteins
12/19/2001	EP1163254A2 Trpm-2 antisense therapy
12/19/2001	EP1163252A2 Compositions, kits, and methods relating to the human fez1 gene, a novel tumor suppressor gene
12/19/2001	EP1163247A1 Pharmaceutical compositions comprising metal complexes
12/19/2001	EP1163239A1 Modified amino-acid amides as cgrp antagonists
12/19/2001	EP1163214A1 Gamma-ketoacid dipeptides as inhibitors of caspase-3
12/19/2001	EP1163010A1 Hemoglobin-antioxidant conjugates
12/19/2001	EP1163003A1 Treatment of lfa-1 associated disorders with increasing doses of lfa-1 antagonist
12/19/2001	EP1162995A2 Medicament for treating diabetes
12/19/2001	EP1162994A1 A means for the prophylactic and therapeutic treatment of streptococcal infections
12/19/2001	EP1162993A2 Use of casb616 polypeptides and polynucleotides for cancer treatment
12/19/2001	EP1162992A2 Cyanovirin conjugates, matrix-anchored cyanovirin and anti-cyanovirin antibody, and related compositions and methods of use
12/19/2001	EP1162991A1 Arginine-rich anti-vascular endothelial growth factor peptides that inhibit growth and metastasis of human tumor cells by blocking angiogenesis
12/19/2001	EP1162990A1 Treatment with small peptides to effect antifibrotic activity
12/19/2001	EP1162985A1 Matrix protein compositions for induction of apoptosis
12/19/2001	EP1162961A2 REGULATION OF HER2/neu ONCONGENE EXPRESSION BY SYNTHETIC POLYAMIDES
12/19/2001	EP1162958A1 Macromolecular pharmaceutical agent solubilized in aerosol propellant
12/19/2001	EP1162945A1 Particle based vaccine composition
12/19/2001	EP1162934A1 Compositions and methods for prevention of photoaging
12/19/2001	EP1162880A1 Human sperm surface antigens
12/19/2001	EP1001990A4 Protein that binds trail
12/19/2001	EP0935605A4 Nucleic acid molecule encoding a bifunctional protein, the protein so encoded and uses thereof
12/19/2001	EP0785794B1 Enteric coated compositions of 1,5-benzodiazepine derivatives having cck antagonistic or agonistic activity
12/19/2001	EP0758901B1 Formulations for il-11
12/19/2001	EP0758387B1 Thymidine kinase mutants
12/19/2001	EP0751785B2 Combinations of thrombolytically active proteins and anticoagulants, and uses thereof
12/19/2001	EP0751779B1 Selectively cleavable linkers based on iminodiacetic acid ester bonds
12/19/2001	EP0746624B1 Vector for liver-specific gene expression
12/19/2001	EP0726942B1 Monoclonal antibodies to foam cells and their pharmaceutical and diagnostic use
12/19/2001	EP0721449B1 Inhibitors of beta-amyloid protein production
12/19/2001	EP0717634B1 Injectable compositions for soft tissue augmentation
12/19/2001	EP0666866B1 Method of isolating biomolecules by ion exchange
12/19/2001	EP0623215B1 Methods and compositions for diagnosing cat scratch disease and bacillary angiomatosis
12/19/2001	EP0586573B1 Endotoxin binding and neutralizing protein and uses thereof
12/19/2001	EP0528820B2 Methods and compositions for the identification, characterization and inhibition of farnesyl protein transferase

1 ... 2146 2147 2148 2149 2150 2151 2152 2153 2154 2155 2156 2157 2158 2159 2160 2161 2162 2163 2164 2165 2166 ... 3163